CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 79,855	$ 81,787
Research and development incentive receivable	909	747
Prepaid expenses and other current assets	4,954	5,344
Total current assets	85,718	87,878
Property and equipment, net	1,194	1,514
Goodwill	17,351	17,351
Right-of-use assets	7,606	8,710
Other assets	1,537	1,723
Total assets	113,406	117,176
Current liabilities:
Accounts payable	3,800	4,283
Accrued expenses	9,128	7,870
Current portion of lease liability	1,164	1,075
Current portion of long-term debt	14,621	795
Total current liabilities	28,713	14,023
Long-term debt, net of discount and current portion	18,733	33,139
Lease liabilities	3,799	4,776
Other liabilities	312	826
Total liabilities	51,557	52,764
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 500,000,000 and 125,000,000 shares authorized as of September 30, 2022 and December 31, 2021, respectively; 68,734,553 and 28,127,657 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	69	28
Additional paid-in capital	409,533	347,374
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(347,634)	(282,871)
Total stockholders’ equity	61,849	64,412
Total liabilities and stockholders’ equity	$ 113,406	$ 117,176